About LambdaVision
LambdaVision is a company based in Farmington (United States) founded in 2009. LambdaVision has raised $7.65 million across 10 funding rounds from investors including NASA, HHS and Boryung Pharmaceutical. The company has 7 employees as of December 31, 2021. LambdaVision offers products and services including Protein-based Artificial Retina. LambdaVision operates in a competitive market with competitors including Rezolute, Aviceda Therapeutics, EyePoint Pharmaceuticals, Molecular Partners and CureVac, among others.
- Headquarter Farmington, United States
- Employees 7 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Lambdavision, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.65 M (USD)
in 10 rounds
-
Latest Funding Round
$7 M (USD), Seed
Nov 05, 2025
-
Investors
NASA
& 8 more
-
Employee Count
7
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of LambdaVision
LambdaVision offers a comprehensive portfolio of products and services, including Protein-based Artificial Retina.
Restores vision by mimicking photoreceptors in retinal diseases.
People of LambdaVision
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of LambdaVision
LambdaVision has successfully raised a total of $7.65M across 10 strategic funding rounds. The most recent funding activity was a Seed round of $7 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in LambdaVision
LambdaVision has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include NASA, HHS and Boryung Pharmaceutical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in tech sectors
|
Locked | Locked | Locked | |
|
Venture capital services for biotech, IT, and innovative sectors in Connecticut.
|
Locked | Locked | Locked | |
|
Early-stage entrepreneurs are accelerated through MassChallenge's program.
|
Locked | Locked | Locked |
Investor details for LambdaVision
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LambdaVision
Investment portfolio details for LambdaVision
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - LambdaVision
Detailed financials for LambdaVision
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lambdavision Comparisons
Peer comparison for LambdaVision
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of LambdaVision
LambdaVision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rezolute, Aviceda Therapeutics, EyePoint Pharmaceuticals, Molecular Partners and CureVac, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for metabolic and orphan diseases are developed by Rezolute.
|
|
| Locked | Locked | Locked |
Biotherapeutics for glycol-immune diseases are developed across multiple therapeutic areas.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for ophthalmic disorders are developed.
|
|
| Locked | Locked | Locked |
Therapeutic solutions for diseases are developed using DARPin technology.
|
|
| Locked | Locked | Locked |
mRNA-based therapeutics against cancer and infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Gene therapy solutions for retinal diseases are developed.
|
Detailed competitors of LambdaVision
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lambdavision
Complete news archive for LambdaVision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LambdaVision
LambdaVision was founded in 2009 and raised its 1st funding round 2 years after it was founded.
LambdaVision is headquartered in Farmington, United States.
LambdaVision is a funded company, having raised a total of $7.65M across 10 funding rounds to date.
As of Dec 31, 2021, the latest employee count at LambdaVision is 7.
LambdaVision was founded in 2009 in Farmington, United States, within the biotechnology sector focused on medical devices. A protein-based retinal prosthesis is developed by the company to address retinal degenerative diseases such as age-related macular degeneration and retinitis pigmentosa. Photochemical properties of retinylidene proteins are utilized to enable high-resolution vision restoration. Operations center on improving patient quality of life through this innovative approach.
LambdaVision's top competitors include EyePoint Pharmaceuticals, Rezolute and Molecular Partners.
LambdaVision offers Protein-based Artificial Retina.
LambdaVision has 9 investors. Key investors include NASA, HHS, Boryung Pharmaceutical, E2MC, and Aurelia Foundry.